solid tumor cancers
solid tumor cancers
Revolutionary Munich Company Doses First Patient with Groundbreaking Cancer Treatment
BIOT
📢 Tubulis from Munich doses first patient with its ADC candidate TUB-040 targeting NaPi2b antigen in ovarian and lung cancer. 🧪
Unlocking Spatial Biology: Overcoming Challenges with MACSima™
BIOT
🔍 Overcoming challenges in spatial biology with the MACSima™ Platform: a game-changer in tissue microenvironment analysis! 🧬🌟🔬🔍🧪💡
